Clinical trial
Chronic Treatment of Alzheimer's Disease With Gamma Frequency Stimulation
NCT04055376 is registered in ClinicalTrials.gov with Massachusetts Institute of Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Chronic Treatment of Alzheimer's Disease With Gamma Frequency Stimulation
- Lead sponsor
- Massachusetts Institute of Technology
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- August 14, 2019
- Completion date
- January 15, 2027
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer dementia, alzheimer disease